PRCT

NASDAQ 已收盘

PROCEPT BioRobotics

19.30 USD
-1.72-8.18%
盘后 19.35 +0.25%
2026-09-15
市值
$1.11B
市盈率
EPS
-1.95
股息率
52 周区间
16.67 – 40.10
成交量
2.00M
Beta
0.90
目标价
21.64
52W 低 16.6752W 高 40.10
价格走势

公司简介

PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology in the United States and internationally. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. The company also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males suffering from lower urinary tract symptoms due to benign prostatic hype...